2011 will be the year we begin to figure out how to best use platelet rich plasma. For almost a decade now, it has been employed as a treatment for a variety of problems. Last year, level one data was published showing how PRP is better than cortisone for tennis elbow. Other data revealed that achilles tendionpathy that is mild to moderate and that had NOT been treated did not get significantly better with PRP and exercise compared to a saline injection and exercise.
This year, large specialty organizations have dedicated time to debate the value of PRP. Via this forums, we will learn from experts. New formulations and indications will emerge as some will fade. These changes will be based on presentation and publication of elite data.